1071522-41-2

Upstream product

• 498-66-8 norborn-2-ene 
• 1189-71-5 isocyanate de chlorosulfonyle 
• 1071518-23-4 (1R,2S,7R,8S)-5-(7-amino-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-3-(4-fluorobenzyl)-6-hydroxy-3-azatricyclo[6.2.1.02,7]undec-5-en-4-one 
• 100-51-6 benzyl alcohol 
• 785027-31-8 (1R,2R,3S,4S)-3-amino-bicyclo[2.2.1]heptane-2-carboxylic acid ethyl ester 
• 1071520-41-6 (1S,2R,3S,4R)-3-(4-fluoro-benzylamino)-bicyclo[2.2.1]heptane-2-carboxylic acid ethyl ester 
• 1071520-32-5 (1S,2S,3R,4R)-3-ethoxycarbonyl-bicyclo[2.2.1]hept-2-yl-ammonium (1'S)-(+)-10-camphorsulfonate 
• 7486-95-5 exo-3-azatricyclo<4.2.1.0^2,5>nonan-4-one 
• 179462-36-3 (±)-cis-3-aminobicyclo[2.2.1]heptane-2-carboxylic acid hydrochloride 
• 95630-75-4 ethyl exo-3-aminobicyclo<2.2.1>heptane-2-exo-carboxylate hydrochloride 
• 105786-35-4 (rac-di-exo)-3-amino-bicyclo[2.2.1]heptane-2-carboxylic acid ethyl ester 
• 1071517-82-2 (1S,2R,3S,4R)-3-(4-fluoro-benzyl)-6-hydroxy-5-(7-iodo-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-3-aza-tricyclo[6.2.1.0(2,7)]undec-5-en-4-one 
• 1071521-45-3 (1R,2S,7R,8S)-5-(7-azido-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-3-(4-fluorobenzyl)-6-hydroxy-3-azatricyclo[6.2.1.02,7]undec-5-en-4-one 

Downstream Products

• 1071519-14-6 (1R,2S,7R,8S)-N-{3-[-3-(4-fluorobenzyl)-6-hydroxy-4-oxo-3-azatricyclo[6.2.1.02,7]undec-5-en-5-yl]-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl}sulfamide 

Relevant academic research and scientific papers

5,6-DIHYDRO-1H-PYRIDIN-2-ONE COMPOUNDS

The invention is directed to 5,6-dihydro-lH-pyridin-2-one compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.